MedPath

The Effects of a Symptom Management Program on Symptom Experience and Physical Functions in Adults with Chronic Obstructive Pulmonary Disease

Phase 1
Completed
Conditions
Chronic obstructive pulmonary disease patients who are aged between 40-80 years.
Chronic obstructive pulmonary disease, symptom management program, symptom experience, physical function
Registration Number
TCTR20230111006
Lead Sponsor
Faculty of Nursing, Thammasat University
Brief Summary

The symptom management program significantly impacted the experimental group's symptom experience and physical function at Weeks 4 and 8. There were significantly improved mean scores for the mMRC, MAF, 6MWD, and CAT. No statistically significant differences were observed in the PSQI, HADS-Anxiety, and HADS-Depression over time.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
102
Inclusion Criteria

1) The participants have stable COPD stage 1-3 (mild-severe)
based on GOLD 2020, diagnosed by a physician and confirmed by spirometry test, which indicated that FEV1/FVC<0.7.
2) Age 40-80 years
3) Participants can perform activities of daily living on their
own. The activities of daily living will be assessed using the Chula Activities of Daily Living Index (CAI). The cut-off score is less than four out of nine, meaning they are less able to conduct daily activities.
4) The participants stay with the family caregivers for at least six months.
5) Participants or family caregivers can access the Line application.
6) Participants are willing to participate in this program.
7) Participants can read, write and communicate in the Thai language.

Exclusion Criteria

1) Participants are stressed by life events such as one of their partner's or a family member's death.
2) Participants have comorbidities, including congestive heart failure, cancer, myocardial infarction, neurological disease, uncontrollability or severe
psychosis, severe schizophrenia, or walking problems.
3) Participants do not want to participate in the study or participate in other self-management programs or pulmonary rehabilitation.
4) Cognitive impairment, severe dementia, or severe Alzheimer's disease.
5) Visual or hearing impairment
6) Hospitalization within four weeks before participating in this study.
7) Difficulty walking on their own.
8) An anxiety or depression score greater than or equal to 11 using the Hospital Anxiety and Depression Scale (HAD), where a score greater than or equal to 11 means having anxiety or depression that is considered a psychiatric disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom experience 0, 4, 8 weeks modified Medical Research Council dyspnea scale, COPD Assessment Test, Multidimensional Assessment of Fatigue, Pittsburgh Sleep Quality Index, Hospital Anxiety and Depression Scale
Secondary Outcome Measures
NameTimeMethod
Physical functions 0,4,8 weeks 6-minute walk test
© Copyright 2025. All Rights Reserved by MedPath